Small-cell carcinoma (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Small-cell carcinoma" in English language version.
refsWebsite
Global rank
English rank
1st place
1st place
11th place
8th place
1,684th place
1,350th place
1,010th place
612th place
194th place
643rd place
low place
low place
406th place
258th place
low place
low place
3,680th place
2,918th place
719th place
636th place
5th place
5th place
5,181st place
3,260th place
low place
low place
low place
low place
18th place
17th place
low place
low place
low place
low place
low place
low place
4,925th place
3,597th place
3,771st place
2,605th place
102nd place
76th place
49th place
47th place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
395th place
252nd place
3,663rd place
5,480th place
Atlasgeneticsoncology.org
- "Atlas of Genetics and Cytogenetics in Oncology and Haematology". atlasgeneticsoncology.org. Archived from the original on 2011-02-23.
asbestos.com
- Selby K. "Small Cell Mesothelioma". The Mesothelioma Center.
atlasgeneticsoncology.org
- "Lung: Translocations in Small Cell Carcinoma". atlasgeneticsoncology.org. Archived from the original on 30 January 2015. Retrieved 30 April 2018.
cancer.ca
- "Treatment for Small Cell Lung Cancer". Canadian Cancer Society. May 2020.
cancer.gov
seer.cancer.gov
- "Small cell carcinoma of the Lung and Bronchus". Surveillance, Epidemiology, and End Results (SEER) Relative Survival Rates by Time Since Diagnosis. U.S. National Cancer Institute. 2016.
- "Small cell carcinoma of the Lung and Bronchus SEER 5-Year Relative Survival Rates, 2011-2017 By Sex and Race/Ethnicity, Ages 50-64, Distant". Surveillance, Epidemiology, and End Results (SEER) Relative Survival Rates by Time Since Diagnosis. U.S. National Cancer Institute. 2016.
- "Table 15.13: Small Cell Cancer of the Lung and Bronchus (Invasive), 5-Year Relative and Period Survival by Race, Sex, Diagnosis Year, Age and Stage at Diagnosis". The SEER Cancer Statistics Review 1975-2015. Surveillance, Epidemiology, and End Results (SEER), U.S. National Cancer Institute.
- "Small cell carcinoma of the Lung and Bronchus SEER Relative Survival Rates by Time Since Diagnosis, 2004-2017 By Stage at Diagnosis, Male, All Races (includes Hispanic), All Ages". Surveillance, Epidemiology, and End Results (SEER) Relative Survival Rates by Time Since Diagnosis. U.S. National Cancer Institute. 2016.
cancer.gov
- "Small Cell Lung Cancer Treatment". National Cancer Institute. U.S.: National Cancer Institute, United States Department of Health and Human Services. 1980-01-01. Retrieved 2019-06-02.
cancer.org
cancernetwork.com
- Sherman CA, Rocha Lima CM, Turrisi AT (October 2000). "Limited small-cell lung cancer: a potentially curable disease". Oncology. 14 (10): 1395–403, discussion 1403–4, 1409. PMID 11098505. Archived from the original on 2019-02-05. Retrieved 2021-08-01.
- "FDA Grants Priority Review to Trilaciclib to Treat Patients with SCLC". Cancer Network. 17 August 2020. Retrieved 2020-12-04.
- "SCLC Prognosis Remains 'Unsatisfactory' Despite Numerous Treatment Options". Cancer Network. 12 April 2023.
clevelandclinic.org
my.clevelandclinic.org
- "Small Cell Lung Cancer: Symptoms, Causes & Treatment". Cleveland Clinic. Retrieved 11 January 2025.
creativecommons.org
- Wang Y, Qu L, Hao Y (August 2009). "[The pitfall of transbronchial lung biopsy in the small cell carcinoma--attach 64 cases immunohistochemistry research.]". Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer. 12 (8): 901–904. doi:10.3779/j.issn.1009-3419.2009.08.14. PMID 20719180.
This article incorporates text available under the CC BY 3.0 license. - Zhang-Yin JT, Girard A, Bertaux M (February 2022). "What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review". Cancers. 14 (4): 879. doi:10.3390/cancers14040879. PMC 8870476. PMID 35205625. This article incorporates text available under the CC BY 4.0 license.
- Wang Y, Xia W, Liu B, Zhou L, Ni M, Zhang R, et al. (June 2021). "Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study". Cancer Imaging. 21 (1) 41. doi:10.1186/s40644-021-00410-w. PMC 8201893. PMID 34120659. This article incorporates text available under the CC BY 4.0 license.
- Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G (December 2022). "Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868 (12): 166557. doi:10.1016/j.bbadis.2022.166557. PMID 36162624.} This article incorporates text available under the CC BY 4.0 license.
curetoday.com
- "FDA Approves Opdivo for Small Cell Lung Cancer Treatment". Cure Today. 17 August 2018.
- "Concurrent Tecentriq Adds First Survival Benefit Seen in Small Cell Lung Cancer in 20 Years". curetoday.com. 25 September 2018.
doi.org
- Nasu K, Hirakawa T, Okamoto M, Nishida M, Kiyoshima C, Matsumoto H, et al. (March 2011). "Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery". Rare Tumors. 3 (1): 18–20. doi:10.4081/rt.2011.e6. PMC 3070456. PMID 21464879.
- Capizzello A, Peponi E, Simou N, Ntaskagiannis D, Tasiou I, Kamina S, et al. (February 2011). "Pure small cell carcinoma of the prostate: a case report and literature review". Case Reports in Oncology. 4 (1): 88–95. doi:10.1159/000324717. PMC 3072185. PMID 21475596.
- Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, et al. (2023). "Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions". CA: A Cancer Journal for Clinicians. 73 (6): 620–652. doi:10.3322/caac.21785. ISSN 1542-4863. PMID 37329269.
- Chan BA, Coward JI (October 2013). "Chemotherapy advances in small-cell lung cancer". Journal of Thoracic Disease. 5 (Suppl 5): S565 – S578. doi:10.3978/j.issn.2072-1439.2013.07.43. PMC 3804877. PMID 24163749.
- Tammela T, Sage J (March 2020). "Investigating Tumor Heterogeneity in Mouse Models". Annual Review of Cancer Biology. 4 (1): 99–119. doi:10.1146/annurev-cancerbio-030419-033413. PMC 8218894. PMID 34164589.
- Pelosi G, Sonzogni A, Galetta D, Perrone F, Braidotti P, Manzotti M, et al. (April 2011). "Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type". Virchows Archiv. 458 (4): 497–503. doi:10.1007/s00428-010-1011-8. PMID 21210145. S2CID 19159554.
- Gotoh M, Yamamoto Y, Huang CL, Yokomise H (November 2004). "A combined small cell carcinoma of the lung containing three components: small cell, spindle cell and squamous cell carcinoma". European Journal of Cardio-Thoracic Surgery. 26 (5): 1047–1049. doi:10.1016/j.ejcts.2004.08.002. PMID 15519208.
- Ismaili N (November 2011). "A rare bladder cancer--small cell carcinoma: review and update". Orphanet Journal of Rare Diseases. 6 (75): 75. doi:10.1186/1750-1172-6-75. PMC 3253713. PMID 22078012.
- Cicin I, Usta U, Karagol H, Uzunoglu S, Kocak Z (2009). "Extrapulmonary small cell carcinoma localized in lymph nodes: is it a different clinical entity?". Acta Oncologica. 48 (3): 354–360. doi:10.1080/02841860802495370. PMID 18979286.
- Nutting C, Horwich A, Fisher C, Parsons C, Dearnaley DP (June 1997). "Small-cell carcinoma of the prostate". Journal of the Royal Society of Medicine. 90 (6): 340–341. doi:10.1177/014107689709000615. PMC 1296316. PMID 9227387.
- Erasmus CE, Verhagen WI, Wauters CA, van Lindert EJ (November 2002). "Brain metastasis from prostate small cell carcinoma: not to be neglected". The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques. 29 (4): 375–377. doi:10.1017/S0317167100002250. PMID 12463494.
- Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H, et al. (October 2012). "Specific organ metastases and survival in small cell lung cancer". Oncology Letters. 4 (4): 617–620. doi:10.3892/ol.2012.792. PMC 3506697. PMID 23205072.
- Ko J, Winslow MM, Sage J (January 2021). "Mechanisms of small cell lung cancer metastasis". EMBO Molecular Medicine. 13 (1): e13122. doi:10.15252/emmm.202013122. PMC 7799359. PMID 33296145.
- Babar SM (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10): 1359–1363. doi:10.1177/1060028013502457. PMID 24259701. S2CID 36759747.
- Titulaer MJ, Verschuuren JJ (2008). "Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms". Annals of the New York Academy of Sciences. 1132 (1): 129–134. Bibcode:2008NYASA1132..129T. doi:10.1196/annals.1405.030. PMID 18567862. S2CID 22482871.
- Leslie M (November 2011). "Mysteries of the cell. How does a cell know its size?". Science. 334 (6059): 1047–1048. doi:10.1126/science.334.6059.1047. PMID 22116854.
- Wang Y, Qu L, Hao Y (August 2009). "[The pitfall of transbronchial lung biopsy in the small cell carcinoma--attach 64 cases immunohistochemistry research.]". Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer. 12 (8): 901–904. doi:10.3779/j.issn.1009-3419.2009.08.14. PMID 20719180. This article incorporates text available under the CC BY 3.0 license.
- Cheng H, Perez-Soler R (January 2018). "Leptomeningeal metastases in non-small-cell lung cancer". The Lancet. Oncology. 19 (1): e43 – e55. doi:10.1016/S1470-2045(17)30689-7. PMID 29304362.
- Ganti AK, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, et al. (December 2021). "Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 19 (12): 1441–1464. doi:10.6004/jnccn.2021.0058. PMC 10203822. PMID 34902832.
- Zhang-Yin JT, Girard A, Bertaux M (February 2022). "What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review". Cancers. 14 (4): 879. doi:10.3390/cancers14040879. PMC 8870476. PMID 35205625. This article incorporates text available under the CC BY 4.0 license.
- Wang Y, Xia W, Liu B, Zhou L, Ni M, Zhang R, et al. (June 2021). "Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study". Cancer Imaging. 21 (1) 41. doi:10.1186/s40644-021-00410-w. PMC 8201893. PMID 34120659. This article incorporates text available under the CC BY 4.0 license.
- Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G (December 2022). "Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868 (12): 166557. doi:10.1016/j.bbadis.2022.166557. PMID 36162624.} This article incorporates text available under the CC BY 4.0 license.
- Singer L, Yom SS (June 2015). "Consolidative radiation therapy for extensive-stage small cell lung cancer". Translational Lung Cancer Research. 4 (3): 211–214. doi:10.3978/j.issn.2218-6751.2015.04.02. PMC 4483471. PMID 26207205.
- Shepherd FA (February 2010). "Surgery for limited stage small cell lung cancer: time to fish or cut bait". Journal of Thoracic Oncology. 5 (2): 147–149. doi:10.1097/JTO.0b013e3181c8cbf5. PMID 20101141.
- Pelayo Alvarez M, Westeel V, Cortés-Jofré M, Bonfill Cosp X (November 2013). "Chemotherapy versus best supportive care for extensive small cell lung cancer". The Cochrane Database of Systematic Reviews (11): CD001990. doi:10.1002/14651858.CD001990.pub3. PMC 11364206. PMID 24282143.
- Stordal B, Pavlakis N, Davey R (December 2007). "A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship" (PDF). Cancer Treatment Reviews. 33 (8): 688–703. doi:10.1016/j.ctrv.2007.07.013. hdl:2123/4068. PMID 17881133.
- Kim SH, Kim MJ, Kim YJ, Chang H, Kim JW, Lee JO, et al. (October 2017). "Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy". Medicine. 96 (42): e8176. doi:10.1097/MD.0000000000008176. PMC 5662365. PMID 29049199.
- Mouri A, Yamaguchi O, Miyauchi S, Shiono A, Utsugi H, Nishihara F, et al. (January 2019). "Combination therapy with carboplatin and paclitaxel for small cell lung cancer". Respiratory Investigation. 57 (1): 34–39. doi:10.1016/j.resinv.2018.09.004. PMID 30528688. S2CID 54471245.
- Qin A, Kalemkerian GP (June 2018). "Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?". Journal of Oncology Practice. 14 (6): 369–370. doi:10.1200/JOP.18.00278. PMID 29894661.
- Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, et al. (October 2019). "Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer". Cancer Discovery. 9 (10): 1372–1387. doi:10.1158/2159-8290.CD-19-0582. PMC 7319046. PMID 31416802.
- Paz-Ares LG, Trigo Perez JM, Besse B, Moreno V, Lopez R, Sala MA, et al. (2019). "Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial". Journal of Clinical Oncology. 37 (supl, abstr 8506): 8506. doi:10.1200/JCO.2019.37.15_suppl.8506. S2CID 190884224.
- Calvo E, Moreno V, Flynn M, Holgado E, Olmedo ME, Lopez Criado MP, et al. (October 2017). "Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study". Annals of Oncology. 28 (10): 2559–2566. doi:10.1093/annonc/mdx357. PMC 5834091. PMID 28961837.
- Farago AF, Drapkin BJ, Lopez-Vilarino de Ramos JA, Galmarini CM, Núñez R, Kahatt C, et al. (January 2019). "ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line". Future Oncology. 15 (3): 231–239. doi:10.2217/fon-2018-0597. PMC 6331752. PMID 30362375.
- Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, et al. (October 2019). "Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial". Annals of Oncology. 30 (10): 1613–1621. doi:10.1093/annonc/mdz278. PMC 6857609. PMID 31504118.
- Smokers defined as current or former smokers of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference:
- Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). "Comparison of aspects of smoking among the four histological types of lung cancer". Tobacco Control. 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
- Ettinger DS, Aisner J (October 2006). "Changing face of small-cell lung cancer: real and artifact". Journal of Clinical Oncology. 24 (28): 4526–4527. doi:10.1200/jco.2006.07.3841. PMID 17008688.
- Muscat JE, Wynder EL (January 1995). "Lung cancer pathology in smokers, ex-smokers and never smokers". Cancer Letters. 88 (1): 1–5. doi:10.1016/0304-3835(94)03608-l. PMID 7850764.
- Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, et al. (February 2019). "Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition". Science Signaling. 12 (567): eaau2922. doi:10.1126/scisignal.aau2922. PMC 6530478. PMID 30723171.
dynamed.com
- "Merkel-cell carcinima". Dynamed. Retrieved 2021-08-01.
ekstrabladet.dk
- "Asbjørn Sennels". Ekstra Bladet [Extra Magazine] (in Danish). 9 July 2023.
etonline.com
- "Dustin Diamond, 'Saved by the Bell' Star, Dead at 44". Entertainment Tonight. February 2021. Retrieved 2021-02-06.
fda.gov
fda.gov
- "FDA grants accelerated approval to lurbinectedin for metastatic small". U.S. Food and Drug Administration (FDA). 15 June 2020. Archived from the original on June 18, 2020. Retrieved 16 June 2020.
This article incorporates text from this source, which is in the public domain. - "Drug Trials Snapshots: Zepzelca". U.S. Food and Drug Administration (FDA). 15 June 2020. Archived from the original on December 22, 2020. Retrieved 28 June 2020. This article incorporates text from this source, which is in the public domain.
- "FDA approves atezolizumab for extensive-stage small cell lung cancer". U.S. Food and Drug Administration. Archived from the original on March 20, 2019.
- "FDA grants accelerated approval to tarlatamab-dlle for extensive stage small cell lung cancer". U.S. Food and Drug Administration (FDA). 16 May 2024. Retrieved 17 May 2024. This article incorporates text from this source, which is in the public domain.
- Office of the Commissioner (2021-02-12). "FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy". FDA. Archived from the original on February 12, 2021. Retrieved 2021-02-16.
accessdata.fda.gov
- "Zepzelca: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on October 19, 2020. Retrieved 15 June 2020.
fredhutch.org
- Richards S (7 February 2019). "A new focus on small cell lung cancer". Fred Hutch.
g1therapeutics.com
- "Trilaciclib | intravenous CDK4/6 inhibitor | G1 Therapeutics, Inc". www.g1therapeutics.com. Retrieved 2020-12-28.
handle.net
hdl.handle.net
- Stordal B, Pavlakis N, Davey R (December 2007). "A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship" (PDF). Cancer Treatment Reviews. 33 (8): 688–703. doi:10.1016/j.ctrv.2007.07.013. hdl:2123/4068. PMID 17881133.
harvard.edu
ui.adsabs.harvard.edu
- Titulaer MJ, Verschuuren JJ (2008). "Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms". Annals of the New York Academy of Sciences. 1132 (1): 129–134. Bibcode:2008NYASA1132..129T. doi:10.1196/annals.1405.030. PMID 18567862. S2CID 22482871.
iarc.fr
- Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. ISBN 978-92-832-2418-1. Archived (PDF) from the original on 23 August 2009. Retrieved 27 March 2010.
iaslc.org
- "Focus on immunotherapy and patient perspective highlight the IASLC 2019 Small Cell Lung Cancer Meeting". The International Association for the Study of Lung Cancer (IASLC). 2019.
mdx.ac.uk
eprints.mdx.ac.uk
- Stordal B, Pavlakis N, Davey R (December 2007). "A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship" (PDF). Cancer Treatment Reviews. 33 (8): 688–703. doi:10.1016/j.ctrv.2007.07.013. hdl:2123/4068. PMID 17881133.
medscape.com
emedicine.medscape.com
medscape.com
- Davenport L (20 December 2016). "Exceptional SCLC Survivors: 5-Year Median Survival". Medscape.
nih.gov
pubmed.ncbi.nlm.nih.gov
- Nasu K, Hirakawa T, Okamoto M, Nishida M, Kiyoshima C, Matsumoto H, et al. (March 2011). "Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery". Rare Tumors. 3 (1): 18–20. doi:10.4081/rt.2011.e6. PMC 3070456. PMID 21464879.
- Capizzello A, Peponi E, Simou N, Ntaskagiannis D, Tasiou I, Kamina S, et al. (February 2011). "Pure small cell carcinoma of the prostate: a case report and literature review". Case Reports in Oncology. 4 (1): 88–95. doi:10.1159/000324717. PMC 3072185. PMID 21475596.
- Basumallik N, Agarwal N (2023). "Small Cell Lung Cancer". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29494065. Retrieved 2023-10-02.
- Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, et al. (2023). "Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions". CA: A Cancer Journal for Clinicians. 73 (6): 620–652. doi:10.3322/caac.21785. ISSN 1542-4863. PMID 37329269.
- Chan BA, Coward JI (October 2013). "Chemotherapy advances in small-cell lung cancer". Journal of Thoracic Disease. 5 (Suppl 5): S565 – S578. doi:10.3978/j.issn.2072-1439.2013.07.43. PMC 3804877. PMID 24163749.
- Argiris A, Murren JR (2001). "Staging and clinical prognostic factors for small-cell lung cancer". Cancer Journal. 7 (5): 437–447. PMID 11693903.
- Tammela T, Sage J (March 2020). "Investigating Tumor Heterogeneity in Mouse Models". Annual Review of Cancer Biology. 4 (1): 99–119. doi:10.1146/annurev-cancerbio-030419-033413. PMC 8218894. PMID 34164589.
- Pelosi G, Sonzogni A, Galetta D, Perrone F, Braidotti P, Manzotti M, et al. (April 2011). "Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type". Virchows Archiv. 458 (4): 497–503. doi:10.1007/s00428-010-1011-8. PMID 21210145. S2CID 19159554.
- Gotoh M, Yamamoto Y, Huang CL, Yokomise H (November 2004). "A combined small cell carcinoma of the lung containing three components: small cell, spindle cell and squamous cell carcinoma". European Journal of Cardio-Thoracic Surgery. 26 (5): 1047–1049. doi:10.1016/j.ejcts.2004.08.002. PMID 15519208.
- Ismaili N (November 2011). "A rare bladder cancer--small cell carcinoma: review and update". Orphanet Journal of Rare Diseases. 6 (75): 75. doi:10.1186/1750-1172-6-75. PMC 3253713. PMID 22078012.
- Cicin I, Usta U, Karagol H, Uzunoglu S, Kocak Z (2009). "Extrapulmonary small cell carcinoma localized in lymph nodes: is it a different clinical entity?". Acta Oncologica. 48 (3): 354–360. doi:10.1080/02841860802495370. PMID 18979286.
- Nutting C, Horwich A, Fisher C, Parsons C, Dearnaley DP (June 1997). "Small-cell carcinoma of the prostate". Journal of the Royal Society of Medicine. 90 (6): 340–341. doi:10.1177/014107689709000615. PMC 1296316. PMID 9227387.
- Erasmus CE, Verhagen WI, Wauters CA, van Lindert EJ (November 2002). "Brain metastasis from prostate small cell carcinoma: not to be neglected". The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques. 29 (4): 375–377. doi:10.1017/S0317167100002250. PMID 12463494.
- Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H, et al. (October 2012). "Specific organ metastases and survival in small cell lung cancer". Oncology Letters. 4 (4): 617–620. doi:10.3892/ol.2012.792. PMC 3506697. PMID 23205072.
- Ko J, Winslow MM, Sage J (January 2021). "Mechanisms of small cell lung cancer metastasis". EMBO Molecular Medicine. 13 (1): e13122. doi:10.15252/emmm.202013122. PMC 7799359. PMID 33296145.
- Babar SM (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10): 1359–1363. doi:10.1177/1060028013502457. PMID 24259701. S2CID 36759747.
- Titulaer MJ, Verschuuren JJ (2008). "Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms". Annals of the New York Academy of Sciences. 1132 (1): 129–134. Bibcode:2008NYASA1132..129T. doi:10.1196/annals.1405.030. PMID 18567862. S2CID 22482871.
- Leslie M (November 2011). "Mysteries of the cell. How does a cell know its size?". Science. 334 (6059): 1047–1048. doi:10.1126/science.334.6059.1047. PMID 22116854.
- Wang Y, Qu L, Hao Y (August 2009). "[The pitfall of transbronchial lung biopsy in the small cell carcinoma--attach 64 cases immunohistochemistry research.]". Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer. 12 (8): 901–904. doi:10.3779/j.issn.1009-3419.2009.08.14. PMID 20719180. This article incorporates text available under the CC BY 3.0 license.
- Cheng H, Perez-Soler R (January 2018). "Leptomeningeal metastases in non-small-cell lung cancer". The Lancet. Oncology. 19 (1): e43 – e55. doi:10.1016/S1470-2045(17)30689-7. PMID 29304362.
- Ganti AK, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, et al. (December 2021). "Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 19 (12): 1441–1464. doi:10.6004/jnccn.2021.0058. PMC 10203822. PMID 34902832.
- Zhang-Yin JT, Girard A, Bertaux M (February 2022). "What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review". Cancers. 14 (4): 879. doi:10.3390/cancers14040879. PMC 8870476. PMID 35205625. This article incorporates text available under the CC BY 4.0 license.
- Wang Y, Xia W, Liu B, Zhou L, Ni M, Zhang R, et al. (June 2021). "Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study". Cancer Imaging. 21 (1) 41. doi:10.1186/s40644-021-00410-w. PMC 8201893. PMID 34120659. This article incorporates text available under the CC BY 4.0 license.
- Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G (December 2022). "Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868 (12): 166557. doi:10.1016/j.bbadis.2022.166557. PMID 36162624.} This article incorporates text available under the CC BY 4.0 license.
- Sherman CA, Rocha Lima CM, Turrisi AT (October 2000). "Limited small-cell lung cancer: a potentially curable disease". Oncology. 14 (10): 1395–403, discussion 1403–4, 1409. PMID 11098505. Archived from the original on 2019-02-05. Retrieved 2021-08-01.
- Singer L, Yom SS (June 2015). "Consolidative radiation therapy for extensive-stage small cell lung cancer". Translational Lung Cancer Research. 4 (3): 211–214. doi:10.3978/j.issn.2218-6751.2015.04.02. PMC 4483471. PMID 26207205.
- Mountain CF (September 1978). "Clinical biology of small cell carcinoma: relationship to surgical therapy". Seminars in Oncology. 5 (3): 272–279. PMID 211638.
- Shepherd FA (February 2010). "Surgery for limited stage small cell lung cancer: time to fish or cut bait". Journal of Thoracic Oncology. 5 (2): 147–149. doi:10.1097/JTO.0b013e3181c8cbf5. PMID 20101141.
- Pelayo Alvarez M, Westeel V, Cortés-Jofré M, Bonfill Cosp X (November 2013). "Chemotherapy versus best supportive care for extensive small cell lung cancer". The Cochrane Database of Systematic Reviews (11): CD001990. doi:10.1002/14651858.CD001990.pub3. PMC 11364206. PMID 24282143.
- Stordal B, Pavlakis N, Davey R (December 2007). "A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship" (PDF). Cancer Treatment Reviews. 33 (8): 688–703. doi:10.1016/j.ctrv.2007.07.013. hdl:2123/4068. PMID 17881133.
- Kim SH, Kim MJ, Kim YJ, Chang H, Kim JW, Lee JO, et al. (October 2017). "Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy". Medicine. 96 (42): e8176. doi:10.1097/MD.0000000000008176. PMC 5662365. PMID 29049199.
- Mouri A, Yamaguchi O, Miyauchi S, Shiono A, Utsugi H, Nishihara F, et al. (January 2019). "Combination therapy with carboplatin and paclitaxel for small cell lung cancer". Respiratory Investigation. 57 (1): 34–39. doi:10.1016/j.resinv.2018.09.004. PMID 30528688. S2CID 54471245.
- Qin A, Kalemkerian GP (June 2018). "Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?". Journal of Oncology Practice. 14 (6): 369–370. doi:10.1200/JOP.18.00278. PMID 29894661.
- Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, et al. (October 2019). "Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer". Cancer Discovery. 9 (10): 1372–1387. doi:10.1158/2159-8290.CD-19-0582. PMC 7319046. PMID 31416802.
- Calvo E, Moreno V, Flynn M, Holgado E, Olmedo ME, Lopez Criado MP, et al. (October 2017). "Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study". Annals of Oncology. 28 (10): 2559–2566. doi:10.1093/annonc/mdx357. PMC 5834091. PMID 28961837.
- Farago AF, Drapkin BJ, Lopez-Vilarino de Ramos JA, Galmarini CM, Núñez R, Kahatt C, et al. (January 2019). "ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line". Future Oncology. 15 (3): 231–239. doi:10.2217/fon-2018-0597. PMC 6331752. PMID 30362375.
- Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, et al. (October 2019). "Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial". Annals of Oncology. 30 (10): 1613–1621. doi:10.1093/annonc/mdz278. PMC 6857609. PMID 31504118.
- Smokers defined as current or former smokers of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference:
- Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). "Comparison of aspects of smoking among the four histological types of lung cancer". Tobacco Control. 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
- Ettinger DS, Aisner J (October 2006). "Changing face of small-cell lung cancer: real and artifact". Journal of Clinical Oncology. 24 (28): 4526–4527. doi:10.1200/jco.2006.07.3841. PMID 17008688.
- Muscat JE, Wynder EL (January 1995). "Lung cancer pathology in smokers, ex-smokers and never smokers". Cancer Letters. 88 (1): 1–5. doi:10.1016/0304-3835(94)03608-l. PMID 7850764.
- Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, et al. (February 2019). "Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition". Science Signaling. 12 (567): eaau2922. doi:10.1126/scisignal.aau2922. PMC 6530478. PMID 30723171.
ncbi.nlm.nih.gov
- Nasu K, Hirakawa T, Okamoto M, Nishida M, Kiyoshima C, Matsumoto H, et al. (March 2011). "Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery". Rare Tumors. 3 (1): 18–20. doi:10.4081/rt.2011.e6. PMC 3070456. PMID 21464879.
- Capizzello A, Peponi E, Simou N, Ntaskagiannis D, Tasiou I, Kamina S, et al. (February 2011). "Pure small cell carcinoma of the prostate: a case report and literature review". Case Reports in Oncology. 4 (1): 88–95. doi:10.1159/000324717. PMC 3072185. PMID 21475596.
- Basumallik N, Agarwal N (2023). "Small Cell Lung Cancer". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29494065. Retrieved 2023-10-02.
- Chan BA, Coward JI (October 2013). "Chemotherapy advances in small-cell lung cancer". Journal of Thoracic Disease. 5 (Suppl 5): S565 – S578. doi:10.3978/j.issn.2072-1439.2013.07.43. PMC 3804877. PMID 24163749.
- Tammela T, Sage J (March 2020). "Investigating Tumor Heterogeneity in Mouse Models". Annual Review of Cancer Biology. 4 (1): 99–119. doi:10.1146/annurev-cancerbio-030419-033413. PMC 8218894. PMID 34164589.
- Ismaili N (November 2011). "A rare bladder cancer--small cell carcinoma: review and update". Orphanet Journal of Rare Diseases. 6 (75): 75. doi:10.1186/1750-1172-6-75. PMC 3253713. PMID 22078012.
- Nutting C, Horwich A, Fisher C, Parsons C, Dearnaley DP (June 1997). "Small-cell carcinoma of the prostate". Journal of the Royal Society of Medicine. 90 (6): 340–341. doi:10.1177/014107689709000615. PMC 1296316. PMID 9227387.
- Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H, et al. (October 2012). "Specific organ metastases and survival in small cell lung cancer". Oncology Letters. 4 (4): 617–620. doi:10.3892/ol.2012.792. PMC 3506697. PMID 23205072.
- Ko J, Winslow MM, Sage J (January 2021). "Mechanisms of small cell lung cancer metastasis". EMBO Molecular Medicine. 13 (1): e13122. doi:10.15252/emmm.202013122. PMC 7799359. PMID 33296145.
- Ganti AK, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, et al. (December 2021). "Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 19 (12): 1441–1464. doi:10.6004/jnccn.2021.0058. PMC 10203822. PMID 34902832.
- Zhang-Yin JT, Girard A, Bertaux M (February 2022). "What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review". Cancers. 14 (4): 879. doi:10.3390/cancers14040879. PMC 8870476. PMID 35205625. This article incorporates text available under the CC BY 4.0 license.
- Wang Y, Xia W, Liu B, Zhou L, Ni M, Zhang R, et al. (June 2021). "Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study". Cancer Imaging. 21 (1) 41. doi:10.1186/s40644-021-00410-w. PMC 8201893. PMID 34120659. This article incorporates text available under the CC BY 4.0 license.
- Singer L, Yom SS (June 2015). "Consolidative radiation therapy for extensive-stage small cell lung cancer". Translational Lung Cancer Research. 4 (3): 211–214. doi:10.3978/j.issn.2218-6751.2015.04.02. PMC 4483471. PMID 26207205.
- Pelayo Alvarez M, Westeel V, Cortés-Jofré M, Bonfill Cosp X (November 2013). "Chemotherapy versus best supportive care for extensive small cell lung cancer". The Cochrane Database of Systematic Reviews (11): CD001990. doi:10.1002/14651858.CD001990.pub3. PMC 11364206. PMID 24282143.
- Kim SH, Kim MJ, Kim YJ, Chang H, Kim JW, Lee JO, et al. (October 2017). "Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy". Medicine. 96 (42): e8176. doi:10.1097/MD.0000000000008176. PMC 5662365. PMID 29049199.
- Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, et al. (October 2019). "Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer". Cancer Discovery. 9 (10): 1372–1387. doi:10.1158/2159-8290.CD-19-0582. PMC 7319046. PMID 31416802.
- Calvo E, Moreno V, Flynn M, Holgado E, Olmedo ME, Lopez Criado MP, et al. (October 2017). "Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study". Annals of Oncology. 28 (10): 2559–2566. doi:10.1093/annonc/mdx357. PMC 5834091. PMID 28961837.
- Farago AF, Drapkin BJ, Lopez-Vilarino de Ramos JA, Galmarini CM, Núñez R, Kahatt C, et al. (January 2019). "ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line". Future Oncology. 15 (3): 231–239. doi:10.2217/fon-2018-0597. PMC 6331752. PMID 30362375.
- Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, et al. (October 2019). "Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial". Annals of Oncology. 30 (10): 1613–1621. doi:10.1093/annonc/mdz278. PMC 6857609. PMID 31504118.
- Smokers defined as current or former smokers of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference:
- Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). "Comparison of aspects of smoking among the four histological types of lung cancer". Tobacco Control. 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
- Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, et al. (February 2019). "Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition". Science Signaling. 12 (567): eaau2922. doi:10.1126/scisignal.aau2922. PMC 6530478. PMID 30723171.
cgap.nci.nih.gov
- "Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer". Archived from the original on 2016-05-29.
dailymed.nlm.nih.gov
- "Zepzelca- lurbinectedin injection, powder, lyophilized, for solution". DailyMed. 15 June 2020. Retrieved 24 September 2020.
onclive.com
- "NICE Cites Cost in Deciding Against Atezolizumab for Frontline Advanced Small Cell Lung Cancer". Reuters. 6 January 2020.
oncolink.org
- "Small Cell Lung Cancer Treatment". National Cancer Institute.
pathologyoutlines.com
- Image by Mikael Häggström, MD. Source for findings: Caroline IM, Underwood CG. "Lung - Small cell carcinoma". Pathology Outlines. Last author update: 20 September 2022
prnewswire.com
- "Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelca (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer" (Press release). Jazz Pharmaceuticals. 15 June 2020. Retrieved 15 June 2020 – via PR Newswire.
- "FDA approves Imdelltra (tarlatamab-dlle), the first and only T-cell engager therapy for the treatment of extensive-stage small cell lung cancer" (Press release). Amgen. 16 May 2024. Retrieved 18 May 2024 – via PR Newswire.
- "PharmaMar and Bionical Emas Launch Expanded Access Program for Lurbinectedin in Relapsed Small Cell Lung Cancer in the U.S." Bionical Emas (Press release) – via www.prnewswire.com.
rarediseases.org
- "Small Cell Lung Cancer". National Organization for Rare Disorders.
reuters.com
ca.reuters.com
- "Canadian regulator considers changes to new drug pricing plan". Reuters. 20 February 2020. Archived from the original on February 22, 2020.
self.com
- Ketteler J (October 16, 2009). "Lung cancer report: "They said it was bronchitis"". Self.
semanticscholar.org
api.semanticscholar.org
- Pelosi G, Sonzogni A, Galetta D, Perrone F, Braidotti P, Manzotti M, et al. (April 2011). "Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type". Virchows Archiv. 458 (4): 497–503. doi:10.1007/s00428-010-1011-8. PMID 21210145. S2CID 19159554.
- Babar SM (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10): 1359–1363. doi:10.1177/1060028013502457. PMID 24259701. S2CID 36759747.
- Titulaer MJ, Verschuuren JJ (2008). "Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms". Annals of the New York Academy of Sciences. 1132 (1): 129–134. Bibcode:2008NYASA1132..129T. doi:10.1196/annals.1405.030. PMID 18567862. S2CID 22482871.
- Mouri A, Yamaguchi O, Miyauchi S, Shiono A, Utsugi H, Nishihara F, et al. (January 2019). "Combination therapy with carboplatin and paclitaxel for small cell lung cancer". Respiratory Investigation. 57 (1): 34–39. doi:10.1016/j.resinv.2018.09.004. PMID 30528688. S2CID 54471245.
- Paz-Ares LG, Trigo Perez JM, Besse B, Moreno V, Lopez R, Sala MA, et al. (2019). "Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial". Journal of Clinical Oncology. 37 (supl, abstr 8506): 8506. doi:10.1200/JCO.2019.37.15_suppl.8506. S2CID 190884224.
uptodate.com
- "Limited-stage small cell lung cancer: Initial management". www.uptodate.com. UpToDate. Retrieved 2019-06-02.
web.archive.org
- "small-cell carcinoma" at Dorland's Medical Dictionary
- Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. ISBN 978-92-832-2418-1. Archived (PDF) from the original on 23 August 2009. Retrieved 27 March 2010.
- Sherman CA, Rocha Lima CM, Turrisi AT (October 2000). "Limited small-cell lung cancer: a potentially curable disease". Oncology. 14 (10): 1395–403, discussion 1403–4, 1409. PMID 11098505. Archived from the original on 2019-02-05. Retrieved 2021-08-01.
- "Zepzelca: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on October 19, 2020. Retrieved 15 June 2020.
- "FDA grants accelerated approval to lurbinectedin for metastatic small". U.S. Food and Drug Administration (FDA). 15 June 2020. Archived from the original on June 18, 2020. Retrieved 16 June 2020. This article incorporates text from this source, which is in the public domain.
- "Drug Trials Snapshots: Zepzelca". U.S. Food and Drug Administration (FDA). 15 June 2020. Archived from the original on December 22, 2020. Retrieved 28 June 2020. This article incorporates text from this source, which is in the public domain.
- "FDA approves atezolizumab for extensive-stage small cell lung cancer". U.S. Food and Drug Administration. Archived from the original on March 20, 2019.
- "Canadian regulator considers changes to new drug pricing plan". Reuters. 20 February 2020. Archived from the original on February 22, 2020.
- Office of the Commissioner (2021-02-12). "FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy". FDA. Archived from the original on February 12, 2021. Retrieved 2021-02-16.
wikimedia.org
commons.wikimedia.org
- Smokers defined as current or former smokers of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference:
- Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). "Comparison of aspects of smoking among the four histological types of lung cancer". Tobacco Control. 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
wikiwix.com
archive.wikiwix.com
- "Lung: Translocations in Small Cell Carcinoma". atlasgeneticsoncology.org. Archived from the original on 30 January 2015. Retrieved 30 April 2018.
- "Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer". Archived from the original on 2016-05-29.
- "Atlas of Genetics and Cytogenetics in Oncology and Haematology". atlasgeneticsoncology.org. Archived from the original on 2011-02-23.
wiley.com
onlinelibrary.wiley.com
- Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, et al. (2023). "Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions". CA: A Cancer Journal for Clinicians. 73 (6): 620–652. doi:10.3322/caac.21785. ISSN 1542-4863. PMID 37329269.
worldcat.org
search.worldcat.org
- Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, et al. (2023). "Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions". CA: A Cancer Journal for Clinicians. 73 (6): 620–652. doi:10.3322/caac.21785. ISSN 1542-4863. PMID 37329269.